Italy: Selva Field Development Update Successful Recovery of €757,000 Performance Bond Funds
Prospex Energy PLC – Final Results for Year ended 31 December 2022 & AGM
Final Results for Year ended 31 December 2022 and Annual General Meeting
Clinical Trial to Employ ANGLE Technology for Cancer Treatment
ANGLE PLC (AIM: AGL, OTCQX: ANPCY), a leader in liquid biopsy technology, has revealed a major contract acquisition with Artios Pharma.
United Oil & Gas PLC – Long Stop Date Extension – North Sea Licence Sale
United Oil & Gas PLC (AIM: “UOG”), an all-encompassing oil and gas company with various assets spanning from production to exploration, has updated its status regarding the tentative sale of
Prospex Energy PLC – Selva Field: Completion of gas plant construction
Italy: Selva Field Development Completion of gas plant construction and connection to the gas grid
EQTEC plc – Audited results for the year ended 31 December 2022
EQTEC plc (AIM: EQT), a global technology innovator powering distributed, decarbonised, new energy infrastructure through its waste-to-value solutions for hydrogen, biofuels and energy generation announces its audited results for the year ended
Prospex Energy PLC – Spain: Project Helios Update
Spain: Project Helios Progress – Hybrid Solar Project Aims to Boost Electricity Output by 60%
ANGLE reports that its order book remains robust, citing 2022 as a year of significant progress.
ANGLE PLC (AIM: AGL, OTCQX: ANPCY), a liquid biopsy company, announced that it achieved a significant milestone in 2022, with clearance from the US Food & Drug Administration (FDA) and
Prospex Energy PLC (AIM:PXEN) Board Appointment
Prospex Energy PLC (AIM: PXEN), the AIM quoted investment company focused on European gas and power projects, is pleased to announce the appointment of Andrew Hay as an independent Non-Executive
Angle PLC Pharma Services Contract with Crescendo Biologics
ANGLE PLC (AIM: AGL, OTCQX: ANPCY) has signed an agreement with Crescendo Biologics, a clinical-stage immuno-oncology company, to offer its advanced Portrait Flex Assay, a liquid biopsy tool, for a
Germany is considering joining Italy and banning AI bot chatGPT
Ulrich Kelber, in an interview with Handelsblatt, stated that Germany is considering banning the AI bot ChatGPT due to concerns over breaches of privacy.